Lest we forget18 Jul 2018 08:18
ValiRx has developed a proprietary technology for the efficient silencing of genes based on natural
mechanisms (GeneICETM)
ValiRx believes that this technology offers considerable advantages over existing gene validation methods,
combining speed, efficiency, selectivity and sustainability as well as its applicability to human cells and in
vivo determinations
ValiRx is employing GeneICE to identify NEW drug targets in hormone regulated cancers (GeneICE Drug
Discovery)
ValiRx is also using GeneICE to develop a new class of therapeutic molecule based on SILENCING of specific
genes at DNA level (GeneICE Therapeutics)